Abstract:The major targets of current drugs used in mental health, such as neurotransmitter receptors and transporters, are based on serendipitous findings from several decades ago, and there is currently a severe drought of new drug targets. There is a pressing need for novel drugs, and much hope has been placed on the use of molecular genetics to help define them. However, despite evidence for a genetic basis to schizophrenia stretching back for over a century, and a heritability of about 80%, the identification of susceptibility genes has been an uphill struggle. Candidate gene studies, which have generally focussed on obvious candidates from the dopamine and serotonin systems, as well as genes involved in brain development, have not generally been successful, although meta-analysis indicates that the dopamine D3 receptor gene (DRD3) and the serotonin receptor gene type 2A (HTR2A) may have a very small influence on risk. Linkage analysis has provided robust evidence of genetic loci, for example, on chromosomes 8p, 13q and 22q, and also implies shared genetic aetiology with bipolar disorder. The identification of these loci together with advances in genetic technology, especially the characterisation of polymorphisms, the understanding of haplotypes and the development of statistical methods, has lead to the identification of several plausible susceptibility genes, including neuregulin 1, proline dehydrogenase and dysbindin. Interestingly, these genes point more towards a role for the glutamate pathway rather than the dopamine pathway in schizophrenia. We have attempted to replicate some of these findings in schizophrenic patients from SW China, and we find significant association with a novel neuregulin 1 haplotype, with proline dehydrogenase polymorphisms, but not with catechol-O-methyltransferase (COMT). The replication of neuregulin 1 association on chromosome 8p by several investigators is the most convincing to date, and the presence of a syndrome similar to dementia praecox of 8p linked families, and the lack of linkage of bipolar disorder to this region is a testament to the ideas of Kraepelin more than 100 years ago.

Further evidence of transmission disequilibrium of the catechol-O-methyl transferase (COMT) gene in schizophrenia in a Chinese population

Significant Linkage and Association Between a Functional (gt)n Polymorphism in Promoter of the N-methyl-D-aspartate Receptor Subunit Gene (GRIN2A) and Schizophrenia.

Association analysis ofCOMT polymorphisms and schizophrenia in a Chinese Han population: A case-control study

The Relationship Between Drd2 Gene Polymorphisms (c957t and C939t) and Schizophrenia: A Meta-Analysis

Association of Catechol-O-methyltransferase Val(108/158) Met Genetic Polymorphism with Schizophrenia, P50 Sensory Gating, and Negative Symptoms in a Chinese Population.

COMT, 5-HTR2A, and SLC6A4 Mrna Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association with Treatment Outcomes

No Association Of Catechol-O-Methyltransferase Polymorphisms With Schizophrenia In The Han Chinese Population

Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.

Morphological Changes in Gray Matter Volume Correlate with Catechol-O-methyl Transferase Gene Val158Met Polymorphism in First-Episode Treatment-Naïve Patients with Schizophrenia

Association between schizophrenia and catechol-O-methyltransferase gene polymorphism

Candidate transmission disequilibrium analysis for quantitative traits in tourette syndrome in a chinese family trio sample

Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions

No association between alleles or genotypes at the dopamine transporter gene and schizophrenia.

The genetics of schizophrenia: glutamate not dopamine?

[Linkage Disequilibrium Analysis of Chromosome 22 and Schizophrenia in a Chinese Population].

Association Study of Clinical Presentation in First-Episode Schizophrenia and Possible Candidate Genes in Chromosome 22

Genetic Study of Neurocognitive Function in First-Episode Schizophrenia

A Family-Based Association Study of T1945C Polymorphism in the Proline Dehydrogenase Gene and Schizophrenia in the Chinese Population

Association Between the COMT Val158Met Polymorphism and Antipsychotic Efficacy in Schizophrenia: an Updated Meta-Analysis.

Analysis of COMT Val158Met Polymorphisms and Methylation in Chinese Male Schizophrenia Patients with Homicidal Behavior

Evidence for Association Between Single Nucleotide Polymorphisms in T Complex Protein 1 Gene and Schizophrenia in the Chinese Han Population